Immunic, inc. to participate in the 2022 wedbush pacgrow virtual healthcare conference

New york , aug. 2, 2022 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that daniel vitt, ph.d., chief executive officer and president, will participate in a fireside chat on tuesday, august 9, at 8:00 am et, during the 2022 wedbush pacgrow virtual healthcare conference, taking place august 9-10, 2022.
IMUX Ratings Summary
IMUX Quant Ranking